Market Trends of Vial Adaptors For Reconstitution Drug Industry
Infectious Diseases Segment is Expected to Hold a Significant Market Share During the Forecast Period
- Vial adapters are used in the reconstitution of drugs designed for the treatment of infectious diseases, as maintaining sterility during the reconstitution process is necessary to prevent contamination and ensure the effectiveness of the medication. These adapters minimize the risk of contamination by reducing the number of needle insertions required during preparation.
- The infectious disease segment is anticipated to witness significant growth during the forecast period owing to factors such as the growing incidence and prevalence of various infectious diseases boosting the demand for effective drugs in the market.
- Additionally, advantages offered by vial adapters, such as their user-friendly nature, ease of preparing injectable medications, their use in treating infectious diseases according to the prescribed guidelines, facilitating the mixing process, and ensuring proper reconstitution of the drugs before administration to patients, are expected to fuel their adoption, thereby contributing to the segment’s growth.
- The high burden of infectious diseases among the population raises the need for early and effective therapeutics, which increases the adoption of vial adapters for safely and efficiently transferring medications between vials and syringes. This is anticipated to augment the segment’s growth. For instance, according to data published by the government of the United Kingdom in April 2024, about 1,196 people were diagnosed with tuberculosis in the first quarter of 2024, registering an increase of 7.5% compared to the same quarter in 2023. In addition, the number of people notified with tuberculosis increased in London (6.4% increase), Northwest (7.0% increase), Southeast (28.1% increase), West Midlands (33.6% increase), and Yorkshire and the Humber (17.7% increase) in the first quarter of 2024 compared to the same quarter in 2023.
- The prevalence and incidence of sexually transmitted diseases (STDs) are increasing, which is primarily due to unprotected sexual encounters. For instance, in October 2023, the UK Health Security Agency (UKHSA) unveiled concerning data on sexually transmitted infections (STIs) and its chlamydia screening initiative. The report underscored a rise in diagnoses, with 392,453 new STIs reported in 2022, prominently featuring gonorrhea and syphilis. This marked a 23.8% surge from the previous year. Gonorrhea cases spiked to 82,592 in 2022, a notable 50.3% increase from the 54,961 cases recorded in England the year prior. The need for effective antibiotic and antiviral preparation for the treatment augments the demand for vial adapters for safe and sterile transfer of the liquid in the vial to maintain its sterility, thus boosting segment growth.
- Various research studies were conducted to determine the effectiveness of vial adapters in maintaining the sterility of single-use vials. For instance, in August 2022, the Journal of Hematology Oncology Pharmacy highlighted the efficacy of vial adapters in preserving the sterility of single-use vials. The study found that closed-system drug-transfer device (CSTD) system vial adapter access devices, along with syringe adapters, maintained microbial sterility in drug vials even after nine days of repeated use. This finding suggested that vial adapters could extend the shelf life of partially used vials. Consequently, the anticipated safety and efficacy of vial adapters are likely to drive their adoption, thereby propelling market growth.
- Hence, owing to the high burden of tuberculosis and sexually transmitted diseases among the population and growing research studies related to vial adapters in maintaining sterility, the segment is expected to grow during the forecast period.
North America is Expected to Hold a Significant Market Share During the Forecast Period
- North America is expected to register a significant market share during the forecast period owing to factors such as the growing burden of chronic and infectious diseases among the population, which propels the demand for effective therapeutics.
- The rise in the geriatric population, who are more prone to develop various chronic and infectious diseases owing to weak immunity and age-related changes in the body, further boosts the demand for novel drugs. In addition, the rising awareness regarding the advantages of viral adapters is raising their adoption for the reconstitution of drugs, which is expected to drive the market’s growth in the region.
- The increasing incidence of chronic diseases is driving the demand for novel treatment, further accelerating the development of drugs in the market. For instance, a study published in Frontiers in Public Health in January 2023 projected that over 143 million Americans aged 50 years and above are expected to suffer from at least one chronic disease by 2050.
- Similarly, according to the American Cancer Society 2024 update, about 2.0 million new cancer cases are expected to be diagnosed in the United States in 2024. Around 5,480 cases of new cancer are likely to be identified in the United States daily. This is anticipated to fuel the demand for sterile and contamination-free reconstitution of the drugs in the market, propelling the adoption of vial adapters during the forecast period.
- Furthermore, there is a surge in the number of autoimmune and metabolic diseases, propelling the demand for drugs and boosting the adoption of vial adapters for safe and sterile transfer of the drugs in injections and vials. For instance, as per data published by Multiple Sclerosis Canada in 2023, on average, about 12 Canadians were diagnosed with multiple sclerosis every day.
- According to data published by the government of Canada in March 2023, almost two in three adults and one in three children and youth were overweight or obese in Canada in 2023. Being overweight raises the risk of developing several chronic diseases, such as cardiovascular disease, diabetes, and cancer, which is projected to foster the country’s market growth during the study period.
- Therefore, owing to factors such as the high burden of multiple sclerosis, obesity, cancer, and other chronic diseases, the market studied is anticipated to witness significant growth during the forecast period.